Is Aldactone (spironolactone) used to treat hypersexuality?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Spironolactone (Aldactone) is NOT used to treat hypersexuality; rather, decreased libido and sexual dysfunction are well-documented side effects of this medication.

Mechanism and Primary Indications

Spironolactone is an aldosterone receptor antagonist and potassium-sparing diuretic with anti-androgenic properties 1. The drug is FDA-approved for treating congestive heart failure, primary hyperaldosteronism, and hypertension—not for managing hypersexuality 1, 2.

Anti-Androgenic Effects Leading to Sexual Dysfunction

The medication's anti-androgenic activity actually causes the opposite effect of what the question implies:

  • Decreased libido is a common side effect, occurring in more than 10% of patients treated with spironolactone 1.

  • In men, spironolactone causes gynecomastia, impotence, and decreased sexual function due to its anti-androgenic properties 1, 3.

  • In women, the drug can cause menstrual irregularities, decreased arousal, and sexual dysfunction 1.

  • A 2019 study documented that spironolactone may cause hormonally associated vestibulodynia and female sexual arousal disorder, with patients experiencing dyspareunia and decreased arousal that resolved after discontinuing the medication 4.

Clinical Context of Sexual Side Effects

The sexual side effects are dose-dependent and well-established:

  • In a study of 699 men with hypertension, gynaecomastia occurred in 6.9% at 50 mg/day and increased to 52.2% at doses of 150 mg or more per day 3.

  • The anti-androgenic effects include decreased testosterone production and competitive inhibition of testosterone and dihydrotestosterone binding to androgen receptors 1.

  • These effects have historically limited the use of spironolactone in clinical practice, particularly in men 3.

Common Pitfalls

Do not confuse spironolactone's anti-androgenic properties with an indication for treating hypersexuality. While the drug does reduce androgen activity and can decrease libido as a side effect, this is an adverse effect rather than a therapeutic indication 1, 2. The medication is used off-label in dermatology for conditions like acne and hirsutism in women precisely because of these anti-androgenic effects, but sexual dysfunction remains an unwanted consequence 1, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Spironolactone's Clinical Applications and Pharmacological Effects

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antialdosterones: incidence and prevention of sexual side effects.

Journal of steroid biochemistry, 1989

Research

[Spironolactone in dermatological treatment. On and off label indications].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.